A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma (Q36028980)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242861%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

title

A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242861%20AND%20SRC:MED&resulttype=core&format=json

metastatic renal cell carcinoma

1 March 2020

main subject

phase II clinical trial

0 references

renal cell carcinoma

1 reference

based on heuristic

inferred from title

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242861%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242861%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Levi A Garraway

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242861%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Richard M Bambury

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242861%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Harry A Drabkin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242861%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Primo N Lara

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242861%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Andrea L Harzstark

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242861%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Nikhil Wagle

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242861%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Robert A Figlin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242861%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Gregory W Smith

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242861%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Toni Choueiri

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242861%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Fredrik Erlandsson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242861%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Damian A Laber

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242861%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

16 November 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242861%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

1 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242861%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242861%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242861%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

178-187

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242861%20AND%20SRC:MED&resulttype=core&format=json

Novel HER2 aptamer selectively delivers cytotoxic drug to HER2-positive breast cancer cells in vitro

1 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560460

RNA-binding protein nucleolin in disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560460

AS1411 aptamer tagged PLGA-lecithin-PEG nanoparticles for tumor cell targeting and drug delivery.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560460

Knocking down nucleolin expression in gliomas inhibits tumor growth and induces cell cycle arrest.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560460

2 October 2017

Cancer statistics, 2012

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560460

Molecular imaging of a cancer-targeting theragnostics probe using a nucleolin aptamer- and microRNA-221 molecular beacon-conjugated nanoparticle

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560460

New insight into clinical development of nucleic acid aptamers.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560460

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560460

Surface Expressed Nucleolin Is Constantly Induced in Tumor Cells to Mediate Calcium-Dependent Ligand Internalization

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560460

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560460

Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560460

Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560460

The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560460

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560460

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560460

Sorafenib in advanced clear-cell renal-cell carcinoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560460

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560460

Inhibition of DNA replication and induction of S phase cell cycle arrest by G-rich oligonucleotides

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560460

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4560460

A scalable, fully automated process for construction of sequence-ready human exome targeted capture libraries

2 October 2017

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-0045-6

Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-0045-6

FGFR2 abnormalities underlie a spectrum of bone, skin, and cancer pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-0045-6

A clear picture of renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-0045-6

Comprehensive molecular characterization of clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-013-0045-6

10.1007/S10637-013-0045-6

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242861%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242861%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

PubMed publication ID

24242861

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24242861%20AND%20SRC:MED&resulttype=core&format=json